In this study, we aimed to confirm the role of LOXL2 in the increased invasiveness of pancreatic cancer cells and to evaluate the clinical impact of LOXL2 in patients with pancreatic cancer. The gene discussed is LOXL2; the disease is familial pancreatic carcinoma.